Table 4: Univariate analysis of factors associated with better outcome in terms of progression free survival and overall survival.
n = 30 |
Univariate Analysis Median OS, 95% CI |
p-valor |
Univariate Analysis Median PFS, 95% CI |
p-value |
Sex Male Female |
19.3 (20.2-35.9) 36.7 (18.4-40.0) |
0.552 |
10.4 (8.58-14.5) 15.8 (13.5-18.6) |
0.083 |
Performance Status 0-1 2 |
36.7 (20.8-42.3) 18.4 (18.4-36.2) |
0.488 |
11 (5.57-16.4) 11.1 (8.2-13.9) |
0.903 |
Histology Non-Squamous Squamous |
36.7 (24.7-40.9) 13.9 (9.58-20.6) |
0.005* |
12.1 (10.5-13.6) 8.1 (4.9-11.2) |
0.041* |
Mediastinal Lymphnode infiltration Yes (N2-3) No (N0-1) |
17.7 (16.2-31.8) 42.7 (28.4-45.3) |
0.05* |
10.4 (5.9-14.8) 14.7 (11.2-18.1) |
0.072 |
Brain Metastases Yes No |
19.3 (17.3-31.3) 26.7 (20.4-39.7) |
0.677 |
12.1 (10.7-13.4) 10.4 (7.7-13.0) |
0.956
|
Maintenance Treatment Yes No |
42.7 (25.6-48.3) 17.7 (15.4-28.2) |
0.068 |
12.1 (8.2-15.9) 9.6 (6.4-12.8) |
0.041* |